RNU6-479P

Across TCGA pan-cancer cohorts, RNU6-479P RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated RNU6-479P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RNU6-479P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-479P expression acts as an unfavorable survival marker, although some lineages such as GBM and BRCA show a favorable association.

ACC, HNSC, and CESC are the cancer types where RNU6-479P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	All	0.210	0.674	<.001	66	view →
HNSC	DFS	Tertile	II,III,IV	0.141	0.399	.001	54	view →
CESC	OS	Tertile	III,IV	0.223	0.648	.024	36	view →
UCS	DFS	Tertile	IV	0.132	0.718	.002	36	view →
OV	OS	Tertile	IV	0.212	0.435	.005	30	view →
GBM	DFS	Tertile	All	0.380	0.225	.006	27	view →
BRCA	DFS	Tertile	All	0.969	0.941	.014	24	view →
UVM	OS	Tertile	III,IV	0.037	0.809	<.001	18	view →
COAD	DFS	Tertile	III,IV	0.253	0.590	.024	18	view →
LUSC	OS	Tertile	IV	0.001	0.651	.025	18	view →
SKCM	DFS	Tertile	IV	0.061	0.513	.033	15	view →
BLCA	OS	Tertile	III,IV	0.493	0.327	.022	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

RNU6-479P–ACC (OS)

Open the ACC breakdown →